(0)

Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Hilton Washington DC/Rockville Hotel & Executive Meeting Ctr.

Oct 18, 2017 7:00 AM - Oct 19, 2017 10:00 PM

1750 Rockville Pike, , Rockville, MD 20852 , USA

Metrics in Patient-Centered Drug Development Conference

Back to Agenda

Session 3: Cultural Change – A Key to Advancing Patient Centricity in Drug Development

Session Chair(s)

K. Kimberly McCleary

K. Kimberly McCleary

Founder and Chief Executive Officer

The Kith Collective, LLC, United States

This session focuses on the role of organizational change in supporting patient-centric practices throughout the medical product life cycle. An expert panel will share experiences in fostering culture change using a combination of strategies. Measuring patient centricity as a means to shift both culture and practice will be explored.

Learning Objective :
  • Define organizational culture and its contribution to fostering patient centricity
  • Identify organizational tools to influence change in culture and practice
  • Describe examples of organizations actively working to change culture in support of adopting patient centricity

    • Speaker(s)

    Kathryn O'Callaghan

    Speaker

    Kathryn O'Callaghan

    FDA, United States

    Assistant Director for Strategic Programs, CDRH

    Stephen Yates, PhD

    Speaker

    Stephen Yates, PhD

    UCB Bioscience, Inc., United States

    Clinical Program Director

    Nikki Levy

    Speaker

    Nikki Levy

    Alkermes, United States

    Vice President, Patient Engagement

    Have an account?

    Be informed and stay engaged.

    Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.